APOE and Alzheimer disease: A study by Chen suggested a small positive effect of APOE-ε4 on cognitive response to rivastigmine at 6 months in Taiwanese AD patients (Chen et al., 2017), and so did a study by Devanand in MCI patients treated with donepezil for 1 year (Devanand et al., 2017).